Gravie, a leading health benefits company, announced today that it has raised $75 million in a Series E round of financing led by Georgian, a growth-stage investor based in Canada, with participation from existing investors FirstMark Capital, AXA Venture Partners, Split Rock Partners and Revelation Partners. The capital will be used to fuel Gravie’s continued growth through investments in all areas of the company including product and technology, sales and marketing, and expansion into new markets through new and existing distribution channels.
